Tactic Pharma LLC (CIK 1727357) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-09-26). Recent activity: Sell MNPR (550,229 shares), Sell MNPR (33,334 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-26 | Monopar Therapeutics (MNPR) | Chief Executive Officer | Sell | 550,229 | $35.0M |
| 2025-04-04 | Monopar Therapeutics (MNPR) | Chief Executive Officer | Sell | 33,334 | $1.2M |
Source: SEC Form 4 filings · as of 2025-09-26